0001567619-20-021624.txt : 20201229
0001567619-20-021624.hdr.sgml : 20201229
20201229105332
ACCESSION NUMBER: 0001567619-20-021624
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201229
DATE AS OF CHANGE: 20201229
EFFECTIVENESS DATE: 20201229
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elucida Oncology, Inc.
CENTRAL INDEX KEY: 0001704594
IRS NUMBER: 471358366
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-380142
FILM NUMBER: 201420982
BUSINESS ADDRESS:
STREET 1: 228 PARK AVENUE SOUTH
CITY: NEW YORK
STATE: NY
ZIP: 10003
BUSINESS PHONE: 805-691-9355
MAIL ADDRESS:
STREET 1: 228 PARK AVENUE SOUTH
CITY: NEW YORK
STATE: NY
ZIP: 10003
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001704594
Elucida Oncology, Inc.
1 Deer Park Drive
Suite E
Monmouth Junction
NJ
NEW JERSEY
08852
646-701-5391
DELAWARE
Claymore Technologies Inc.
None
Corporation
true
Geno
Germano
1 Deer Park Drive
Suite E
Monmouth Junction
NJ
NEW JERSEY
08852
Executive Officer
Director
Tim
Boris
1 Deer Park Drive
Suite E
Monmouth Junction
NJ
NEW JERSEY
08852
Director
Michael
Smith
1 Deer Park Drive
Suite E
Monmouth Junction
NJ
NEW JERSEY
08852
Director
Robert
Essner
1 Deer Park Drive
Suite E
Monmouth Junction
NJ
NEW JERSEY
08852
Executive Officer
Director
Teresa
Ressel
1 Deer Park Drive
Suite E
Monmouth Junction
NJ
NEW JERSEY
08852
Director
Ulrich
Wiesner
1 Deer Park Drive
Suite E
Monmouth Junction
NJ
NEW JERSEY
08852
Director
Robert
Ruffolo
1 Deer Park Drive
Suite E
Monmouth Junction
NJ
NEW JERSEY
08852
Director
Eliel
Bayever
1 Deer Park Drive
Suite E
Monmouth Junction
NJ
NEW JERSEY
08852
Executive Officer
Kai
Ma
1 Deer Park Drive
Suite E
Monmouth Junction
NJ
NEW JERSEY
08852
Executive Officer
Gregory
Adams
1 Deer Park Drive
Suite E
Monmouth Junction
NJ
NEW JERSEY
08852
Executive Officer
Biotechnology
No Revenues
- 06b
true
0001567619-20-019011
2020-10-28
false
true
true
false
12500
Maxim Group LLC
12078
None
None
405 Lexington Avenue
New York
NY
NEW YORK
10174
All States
false
35000000
32552878
2447122
false
303
3255288
0
In addition, the Company issued the placement agent Warrants to purchase 4,388,888 shares of common stock of Elucida in connection with the offering.
0
false
Elucida Oncology, Inc.
/s/ Geno Germano
Geno Germano
CEO
2020-12-29